May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Novel PAX6 Gene Mutations in patients with Aniridia in India
Author Affiliations & Notes
  • S. Periasamy
    Genetics, Aravind Eye Hospital, Madurai Tamilnadu, India
  • G. Neethirajan
    Genetics, Aravind Eye Hospital, Madurai Tamilnadu, India
  • S.R. Krishnadas
    Genetics, Aravind Eye Hospital, Madurai Tamilnadu, India
  • P. Vijayalakshmi
    Genetics, Aravind Eye Hospital, Madurai Tamilnadu, India
  • Footnotes
    Commercial Relationships  S. Periasamy, None; G. Neethirajan, None; S.R. Krishnadas, None; P. Vijayalakshmi, None.
  • Footnotes
    Support  Indian Council of Medical Research, New Delhi, INDIA
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2464. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Periasamy, G. Neethirajan, S.R. Krishnadas, P. Vijayalakshmi; Novel PAX6 Gene Mutations in patients with Aniridia in India . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2464.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Mutations in the transcription factor gene PAX6 have been shown to be the cause of aniridia phenotype. The purpose of this study is to investigate genotype/phenotype correlations in aniridia patients with PAX6 mutations in the south Indian population. Methods: Eight clinically well–characterized sporadic aniridia individuals with their unaffected family members (27) and normal healthy controls (80) were studied. Total genomic DNA was isolated from peripheral blood of aniridia patients and controls. The coding exons of the human PAX6 gene were amplified by PCR. Nucleotide changes were detected by single strand conformation polymorphism analysis (SSCP) followed by automated sequencing. Results:The sequencing results revealed novel PAX6 mutations in four patients with sporadic aniridia: c.1180insA, c.715ins5, c.1201delA, and c.901delA. Three nonsense mutations: c.1080 C>T, c.482C>A, c.830G>A. were also reported here for the first time in South Indian population, even though these mutations were reported in other populations. A neutral polymorphism was detected (IVS9–12C>T) at the boundary of intron 9 and exon 10. Conclusion:Most genetic analysis indicates that haploinsuffiency of the PAX6 gene causes the classic aniridia phenotype. Most mutations detected in aniridia patients results in premature termination of translation from the mutant allele. We add four novel PAX6 gene mutations to the existing spectrum of mutations in Indian population. Our study supports the hypothesis that mutations in the PAX6 gene cause the pathological aniridia phenotype.

Keywords: gene screening 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×